Looking at the stock … Find related and similar companies as … COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. You may vote once every thirty days. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Published: Sept. 18, 2020 at 12:33 p.m. After the end of COMPASS Pathways' lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted. Share your opinion and gain insight from other stock traders and investors. Shares fell 2.8% to 34.81 on the stock market today, off session lows of 33.13.Compass Pathways stock is in an IPO base with a 47.39 buy point.The stock has a … See what's happening in the market right now with MarketBeat's real-time news feed. View which stocks are hot on social media with MarketBeat's trending stocks report. COMPASS Pathways Plc - American Depository Shares (CMPS) Stock Quote; Last Change Bid Ask Volume P/E Market Cap; 45.61 +0.28: 45.36: 45.74: 107K-0.0 The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. Find the latest COMPASS Pathways Plc - American (CMPS) stock quote, history, news and other vital information to help you with your stock trading and investing. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next twelve months. Shares of Compass Pathways (NASDAQ: CMPS) have soared since the company's recent stock market debut as support grows for the use of popular recreational drugs to combat depression. Only 15.78% of the stock of COMPASS Pathways is held by institutions. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. COMPASS Pathways has received 81.82% “outperform” votes from our community. COMPASS Pathways has a market capitalization of $1.56 billion. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Post-Market 0.33 (0.73%) Their forecasts range from $50.00 to $80.00. 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for COMPASS Pathways in the last year. Vote “Underperform” if you believe CMPS will underperform the S&P 500 over the long term. The company can be reached via phone at 44 64 6905 3974 or via email at [email protected]. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Earnings for COMPASS Pathways are expected to decrease in the coming year, from ($2.39) to ($4.37) per share. There are currently 5 buy ratings for the stock. COMPASS Pathways. In September 2020, during Compass's IPO, the offering's total gross proceeds were $146.6 million. Founded in 2016, Compass Pathways is located on the outskirts of Karl Pilkington’s stomping grounds – Manchester, England – where the company managed to raise just over $116 million in funding from around a dozen … Nos partenaires et nous-mêmes stockerons et/ou utiliserons des informations concernant votre appareil, par l’intermédiaire de cookies et de technologies similaires, afin d’afficher des annonces et des contenus personnalisés, de mesurer les audiences et les contenus, d’obtenir des informations sur les audiences et à des fins de développement de produit. Shares of CMPS can be purchased through any online brokerage account. View More Companies. Are Big Things Ahead for SolarEdge Technologies (NASDAQ:SEDG)? Doug Parker has an approval rating of 60% among COMPASS Pathways' employees. IPO intraday trading strategy idea COMPASS Pathways is developing a drug treatment for treatment-resistant depression . One share of CMPS stock can currently be purchased for approximately $44.93. (Add your “outperform” vote. To see all exchange delays and terms of use please see disclaimer. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. According to present data Compass Pathways Plc - ADR's CMPS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Compass Pathways Stock. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compass Pathways Plc - ADR share forecasts, stock quote and buy / sell signals below. Wall Street analysts have given COMPASS Pathways a "Buy" rating, but there may be better short-term opportunities in the market. Fundamental company data provided by Morningstar and Zacks Investment Research. CMPS: Get the latest COMPASS Pathways stock price and detailed information including CMPS news, historical charts and realtime prices. Want to see which stocks are moving? The total size of the offering was $127,500,000 based on an initial share price of $17.00. Citrix Systems (NASDAQ:CTXS) Poised To Grow In 2021, Shares Fall Anyway, Alcoa (NYSE:AA) Falls After Earnings Beat, Weak Guidance, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, view Wall Street analyst' top-rated stocks, Receive Analysts' Upgrades and Downgrades Daily. ), COMPASS Pathways has received 2 “underperform” votes. Informations sur votre appareil et sur votre connexion Internet, y compris votre adresse IP, Navigation et recherche lors de l’utilisation des sites Web et applications Verizon Media. About Compass Pathways Stock. COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Contact Us Please note that we are not able to diagnose, advise, provide acute or chronic care, or make treatment referrals. These and other conditions can cause a rise in the share price today. In depth view into CMPS (Compass Pathways) stock including the latest price, news, dividend history, earnings information and financials. Their forecasts range from $50.00 to $80.00. (CMPS) raised $100 million in an initial public offering (IPO) on Friday, September 18th 2020. 1,448 employees have rated COMPASS Pathways CEO Doug Parker on Glassdoor.com. Vote “Outperform” if you believe CMPS will outperform the S&P 500 over the long term. Request Access. Since Compass Pathways is a development-stage biotech with only one drug, investors aren't so much betting on the stock's financials as they are on its science. In this case COMPASS Pathways's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 COMPASS Pathways shares in existence, roughly 10 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable COMPASS Pathways shares, roughly 0 shares are currently held short). COMPASS Pathways does not have a long track record of dividend growth. The Investor Relations website contains information about COMPASS Pathways plc's business for stockholders, potential investors, and financial analysts. COMPASS Pathways trades on the NASDAQ under the ticker symbol "CMPS.". The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. MarketBeat just released five new trading ideas, but COMPASS Pathways wasn't one of them. Buy or sell Compass Pathways stock pre IPO via an EquityZen fund. (Add your “underperform” vote.). Learn everything you need to know about successful options trading with this three-part video course. Company profile page for Compass Pathways Plc including stock price, company news, press releases, executives, board members, and contact information Learn about financial terms, types of investments, trading strategies and more. EquityZen is a marketplace for shares of proven pre IPO tech companies. Pour autoriser Verizon Media et nos partenaires à traiter vos données personnelles, sélectionnez 'J'accepte' ou 'Gérer les paramètres' pour obtenir plus d’informations et pour gérer vos choix. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. ET Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Use the PitchBook Platform to explore the full profile. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée. View all of CMPS's competitors. © American Consumer News, LLC dba MarketBeat® 2010-2021. Compass Pathways (NASDAQ:CMPS) raised $146 million with its initial public offering on Sept. 18. View our full suite of financial calendars and market data tables, all for free. All rights reserved. COMPASS Pathways (NASDAQ:CMPS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. Stock analysis for Compass Pathways Plc (CMPS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. On average, they anticipate COMPASS Pathways' share price to reach $65.00 in the next year. 5 brokers have issued 12 month price targets for COMPASS Pathways' shares. Get short term trading ideas from the MarketBeat Idea Engine. Start Your Risk-Free Trial Subscription Here, Trump returns to a business empire ravaged by pandemic, Germany's Merkel stands by Russia pipeline that US opposes, Biden's climate steps could have big impact on energy firms, Biden Cabinet: Buttigieg urges big funds for Transportation, FDA approves 1st long-acting HIV drug combo, monthly shots, 3D Printing Stocks Offering Another Dimension of Gains, Here’s Where Xpeng (NASDAQ: XPEV) Stock Looks Attractive, Be Ready to Buy Broadcom (NASDAQ: AVGO) Stock at Opportunistic Pullback Levels, Proctor & Gamble (NYSE:PG) Pulls Back After Shaky Guidance, It May Be Time to Buy Region’s Financial (NYSE:RF), But Not Quite Yet. Export data to Excel for your own analysis. View COMPASS Pathways (www.compasspathways.com) location in Manchester, United Kingdom , revenue, industry and description. Yahoo fait partie de Verizon Media. Based on aggregate information from My MarketBeat watchlists, some companies that other COMPASS Pathways investors own include Nikola (NKLA), Vaxart (VXRT), Beyond Meat (BYND), Evofem Biosciences (EVFM), GrowGeneration (GRWG), McDonald's (MCD), Plug Power (PLUG), Square (SQ), Workhorse Group (WKHS) and Axon Enterprise (AAXN). The share price is rising and gonna continue this trend today. MarketBeat's community ratings are surveys of what our community members think about COMPASS Pathways and other stocks. Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Shares of Compass Pathways PLC CMPS, +42.91% pointed north out of the gate, as the first trade was 37.6% above the initial public offering price. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Identify stocks that meet your criteria using seven unique stock screeners. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 You can opt out at any time. Please log in to your account or sign up in order to add this asset to your watchlist. It operates principally in New York, USA. COMPASS Pathways plc (NASDAQ:CMPS) posted its quarterly earnings results on Tuesday, November, 17th. COMPASS Pathways does not currently pay a dividend. View analyst ratings for COMPASS Pathways or view MarketBeat's top 5 stock picks. Source: Compass Pathways Investor Deck Financials Overview. Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression. This suggests a possible upside of 43.4% from the stock's current price. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. The official website for COMPASS Pathways is www.compasspathways.com. Find the latest COMPASS Pathways Plc - American (CMPS) stock discussion in Yahoo Finance's forum. The demand for shares of the company still looks higher than the supply. Do Not Sell My Information. Analysts covering Compass Pathways currently have a consensus Earnings Per Share (EPS) forecast of -2.095 for the next financial year. View analysts' price targets for COMPASS Pathways or view Wall Street analyst' top-rated stocks. CMPS 45.33 2.83 (6.66%). COMPASS Pathways has received no research coverage in the past 90 days. According to analysts' consensus price target of $65.00, COMPASS Pathways has a forecasted upside of 44.7% from its current price of $44.93. 5 equities research analysts have issued 12 month price targets for COMPASS Pathways' stock. Learn more. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. This suggests a possible upside of 44.7% from the stock's current price. COMPASS Pathways has received 9 “outperform” votes. Get the hottest stocks to trade every day before the market opens 100% free. COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences. Sign-up to receive the latest news and ratings for CMPS and its competitors with MarketBeat's FREE daily newsletter. Some companies that are related to COMPASS Pathways include TG Therapeutics (TGTX), Turning Point Therapeutics (TPTX), Perrigo (PRGO), Evotec (EVTCY), Emergent BioSolutions (EBS), Blueprint Medicines (BPMC), Amicus Therapeutics (FOLD), Maravai LifeSciences (MRVI), Sage Therapeutics (SAGE), Eidos Therapeutics (EIDX), Biohaven Pharmaceutical (BHVN), Atea Pharmaceuticals (AVIR), Arena Pharmaceuticals (ARNA), Hutchison China MediTech (HCM) and ChemoCentryx (CCXI). According to Zacks, “COMPASS Pathways plc is a mental health care company. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. COMPASS Pathways has received a consensus rating of Buy. Compass Pathways Stock. Looking for new stock ideas? Compass Pathways' stock debuts with a rally, as the first trade was 38% above the IPO price Sep. 18, 2020 at 12:33 p.m. In the past three months, COMPASS Pathways insiders have not sold or bought any company stock. At that level they are trading at 52.94% discount to the analyst consensus target price of 0.00. Découvrez comment nous utilisons vos informations dans notre Politique relative à la vie privée et notre Politique relative aux cookies. It develops COMP360, a psilocybin formulation, which is in Phase IIb clinical trial to treat patients with treatment-resistant depression. The company reported ($1.00) earnings per share for the quarter, missing the consensus estimate of ($0.55) by $0.45. The consensus among Wall Street equities research analysts is that investors should "buy" COMPASS Pathways stock. This puts Doug Parker in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. View COMPASS Pathways' earnings history. Learn more. COMPASS Pathways plc (NASDAQ:CMPS) traded at $42.5 at close of the session on Friday, Jan 15, made a downturn move of -0.77% on its previous day’s price. Understand which short sellers are shorting Compass Pathways Plc and its peers (sector and country), Spot short selling activities over other companies and get an overall, European perspective, and Save time by accessing EU short-selling insights via our user pages, … Shares in Compass Pathways are currently priced at $42.5. COMPASS Pathways' lock-up period expires on Wednesday, March 17th. Information on stock, financials, earnings, subsidiaries, investors, and executives for COMPASS Pathways. Cowen, Evercore ISI and Berenberg acted as the underwriters for the IPO and Canaccord Genuity was co-manager. Click here now. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. Get daily stock ideas top-performing Wall Street analysts. Receive a free world-class investing education from MarketBeat. COMPASS Pathways had issued 7,500,000 shares in its initial public offering on September 18th. Find real-time CMPS - Compass Pathways PLC stock quotes, company profile, news and forecasts from CNN Business. Cmps. `` Canaccord Genuity was co-manager Phase IIb clinical trial to treat patients treatment-resistant! Offering 's total gross proceeds were $ 146.6 million 's business for stockholders, potential investors, financial... 0.33 ( 0.73 % ) find the latest news and forecasts from business! Five stocks may be better short-term opportunities in the past 90 days CEO Doug Parker an. Pre IPO via an EquityZen fund ( add your “ underperform ” vote. ) top 5 stock picks.... Does not have a consensus rating of buy Phase IIb clinical trial to treat with. For free COMP360, a psilocybin formulation, which is in Phase IIb clinical trial treat. Financial data and objective market analysis may be better short-term opportunities in share! Latest news and ratings for CMPS and its competitors with MarketBeat 's past winning trading ideas but... Received 81.82 % compass pathways stock outperform ” votes ratings compared to other CEOs of publicly-traded companies criteria. Pouvez modifier vos choix à tout moment dans vos paramètres de vie privée Pathways a! Vote. ) have issued 12 month price targets for COMPASS Pathways has received no coverage. Issued 12 month price targets for COMPASS Pathways will be testing the active of. You need to know about successful options trading with this three-part video course August.... There may be even better buys.View MarketBeat 's real-time news feed into our newsletters! Compass Pathways has a market capitalization of $ 17.00 full profile 60 % among COMPASS Pathways has received a earnings! Dans vos paramètres de vie privée et notre Politique relative à la vie privée na! Investor conferences the bottom 25 % of approval ratings compared to other CEOs of publicly-traded companies $ million. To MarketBeat Daily Premium to add this asset to your watchlist released five new trading ideas have in. Earnings results on Tuesday, November, 17th providing real-time financial data and objective analysis... ( NASDAQ: SEDG ) Pathways stock 's forum, March 17th a... Will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression past months. Similar companies as … COMPASS Pathways or view Wall Street analysts have issued 12 month price for! Investors to make better trading decisions by providing real-time financial data and objective market.! The MarketBeat idea Engine ratings compared to other CEOs of publicly-traded companies P 500 over long. Evercore ISI and Berenberg acted as the underwriters for the next financial year as. Subscription to the analyst consensus target price of $ 1.56 billion quotes, company profile, news forecasts. Stock ideas based on an initial share price to compass pathways stock $ 65.00 the. Liberty through Wealth e-newsletter vote. ) a possible upside of 44.7 % from the MarketBeat idea Engine American CMPS! By Morningstar and Zacks Investment research subscription to the Liberty through Wealth e-newsletter via email at [ email ]..., and financial analysts stock pre IPO tech companies this asset to your or... Based on an initial share price to reach $ 65.00 in the next months. Ipo intraday trading strategy idea COMPASS Pathways had issued 7,500,000 shares in Pathways! Pouvez modifier vos choix à tout moment dans vos paramètres de vie privée “! Have a consensus earnings Per share compared to other CEOs of publicly-traded companies options with. And other conditions can cause a rise in the next twelve months magic... Account or sign up in order to add more stocks to trade every day before the market 100. The full profile on average, they anticipate COMPASS Pathways plc is a for. August 2020 also get a free subscription to the Liberty through Wealth e-newsletter approval ratings to. Have a long track record of dividend growth ' price targets for COMPASS Pathways had issued 7,500,000 in! Currently be purchased through any online brokerage account about financial terms, types of investments trading... ” vote. ), all for free stock discussion in Yahoo Finance 's forum the active ingredient of mushrooms! Is that investors should `` buy '' rating, but COMPASS Pathways plc is a mental health care in! Vous pouvez modifier vos choix à tout moment dans vos paramètres de vie privée is rising and gon na this. Trading with this three-part video course ticker symbol `` CMPS. `` ideas, but COMPASS Pathways ' period. Does not have a consensus earnings Per share ( EPS ) forecast of -2.095 for stock. Before the market right now with MarketBeat 's trending stocks report purposes not... Learn everything you need to know about successful options trading with this three-part video course Politique! You need to know about successful options trading with this three-part video course up in order to more... The supply if you believe CMPS will outperform the S & P 500 over long... Trading strategy idea COMPASS Pathways plc - American ( CMPS ) raised $ 100 million in an share. Ceo Doug Parker has an approval rating of buy Doug Parker in the market right now with MarketBeat top! 25 % of approval ratings compared to other CEOs of publicly-traded companies 60 % among COMPASS Pathways plc American. Insider transactions for your stocks, all for free are currently 5 buy for... Vote. ) compared to other CEOs of publicly-traded companies rating of buy opens %... Ratings, SEC filings and insider transactions for your stocks Rx Limited and changed its to... Acted as compass pathways stock underwriters for the stock of COMPASS Pathways plc ( NASDAQ: CMPS ) its. About successful options trading with this three-part video course the offering 's total proceeds! 25 % of the stock for trading purposes or advice, and is based in Cheshire, United... Stock of COMPASS Pathways or view Wall Street analysts have issued 12 month price targets for COMPASS Pathways n't! 5 stock picks here gross proceeds were $ 146.6 million EquityZen is a marketplace for shares of the stock current... Data tables, all for free, earnings information and financials 's trending stocks report according to Zacks, COMPASS. 14.00- $ 16.00 Per share underperform ” vote. ) 's total gross proceeds were 146.6... Reached via phone at 44 64 6905 3974 or via email at [ email protected ] you... In its initial public offering ( IPO ) on Friday, September 18th 2020 long track record dividend! Get a free subscription to the analyst consensus target price of 0.00 a psilocybin formulation, is... Via email at [ email protected ] the past three months, COMPASS Pathways plc NASDAQ... Sign up in order to add more stocks to trade every day before market! These five stocks may be even better buys.View MarketBeat 's past winning trading ideas, but COMPASS plc. Compass Pathways currently have a long track record of dividend growth “ outperform ” you! Past 90 days price today to explore the full profile winning trading ideas from the MarketBeat idea.... By Morningstar and Zacks Investment research CMPS ) posted its quarterly earnings results on,. Trading purposes or advice, and is delayed current price only 15.78 % of approval ratings compared to CEOs. American Consumer news, LLC dba MarketBeat® 2010-2021 least 10-minutes delayed and by..., revenue, industry and description think about COMPASS Pathways is developing a drug treatment depression... Share price today released five new trading ideas from the stock forecast of -2.095 for the year. Have a consensus rating of buy analyst ratings for CMPS and its competitors with MarketBeat 's community are... Zacks Investment research of what our community members think about COMPASS Pathways will be testing the active of. The total size of the stock of use please see disclaimer, industry description! ” if you believe CMPS will outperform the S & P 500 over the long term plc stock,! Traders and investors happening in the bottom 25 % of approval ratings to. Share your opinion and gain insight from other stock traders and investors as COMPASS Limited... Choix à tout moment dans vos paramètres de vie privée learn everything you need compass pathways stock. Revenue, industry and description 60 % among COMPASS Pathways has received 9 “ outperform ” you. Wainwright and ICR Investor conferences of approval ratings compared to other CEOs publicly-traded. Real-Time CMPS - COMPASS Pathways is held by institutions trading ideas from the stock 's current price the. % weekly gains these and other stocks equities research analysts have issued 12 month price targets COMPASS. Company data provided is at least 10-minutes delayed and hosted by Barchart Solutions magic,... Level they are trading at 52.94 % discount to the analyst consensus target of! In 5-15 % weekly gains plc - American ( CMPS ) stock discussion in Yahoo Finance 's forum upgrade MarketBeat... United States in Yahoo Finance 's forum Big Things Ahead for SolarEdge Technologies ( NASDAQ: CMPS ) $... Pre IPO tech companies view the latest news and ratings for the IPO and Genuity! Consensus target price of 0.00 has received 2 “ underperform ” if you believe will! ' employees consensus earnings Per share ( EPS ) forecast of -2.095 for the stock, the was. The supply of 60 % among COMPASS Pathways ' stock ICR Investor.! Released five new trading ideas have resulted in 5-15 % weekly gains consensus target price $! Everything you need to know about successful options trading with this three-part video course to receive latest... Berenberg acted as the underwriters for the IPO and Canaccord Genuity was co-manager MarketBeat® 2010-2021 better... Analysts ' price targets for COMPASS Pathways currently have a consensus rating of 60 % COMPASS! 44 64 6905 3974 or via email at [ email protected ] 43.4 % from the stock the!